Quality & compliance
The unglamorous work that makes a medicine trustworthy.
Quality at Oxalas is a set of controls that run from the manufacturer’s line to the pharmacy shelf and back — because a medicine is only as good as the system that made, moved, labelled and monitored it.
Manufacturing
We work with manufacturing partners that operate under Good Manufacturing Practice and hold the licences required by the authority of each market. Specifications, methods and release criteria are agreed before production and audited during the relationship.
Supply chain
Products move through licensed distributors under controlled storage and transport conditions, with traceability from batch release to point of sale. We do not supply through unlicensed channels, in any market.
Regulatory compliance
Each product is registered or notified as the authority requires — the FDA in the United States, the SFDA in Saudi Arabia, MOHAP in the United Arab Emirates and the EDA in Egypt — and its labelling, leaflet and promotional material follow that market’s rules.
Pharmacovigilance
Reports of side effects, product complaints and quality issues are recorded, assessed and forwarded to the relevant authority within the required timelines. Safety information in our leaflets and prescribing information is kept current in every market.
If you or someone you care for has experienced a side effect with an Oxalas medicine, please tell a healthcare professional and report it to us at [email protected]. Reports can also be made to the health authority in your country.
Information and privacy
Product information is written for the reader it is meant for — plain language for patients and consumers, full prescribing information for healthcare professionals. Personal data received through enquiries or safety reports is handled under our privacy policy and the data-protection rules of each market.